100 results
Keyword Beclomethasone Remove keyword
-
List item
Orphan designation: Beclomethasone 17, 21-dipropionate for: Treatment of intestinal graft-versus-host disease
Date of designation: 13/03/2002, Positive, Last updated: 08/06/2020Beclomethasone 17, 21-dipropionate Overview … Voisin Consulting, France, for beclomethasone 17,21-dipropionate (oral … immune factors are inhibited. Beclomethasone 17,21-dipropionate is a corticosteroid … -
List item
Press release: DOR BIOPHARMA UK Ltd withdraws marketing authorisation application for orBec (beclomethasone dipropionate)
Last updated: 23/05/2008authorisation application for orBec (beclomethasone dipropionate … authorisation for the medicine orBec (beclomethasone dipropionate) 1 mg tablets … application for orBec (beclomethasone dipropionate) The European … -
List item
Press release: EMA completes review of inhaled corticosteroids for chronic obstructive pulmonary disease
Last updated: 29/04/2016include the active substances beclomethasone, budesonide, flunisolide … include the active substances beclomethasone, budesonide, flunisolide … that widens the airways). Beclomethasone, budesonide, flunisolide … -
List item
Referral: Kantos Master
beclometasone dipropionate, formoterol fumarate, associated names: Kantos, Formodual, Foster, Inuxair, Innovair and associated names, Article 13 referrals
Status: European Commission final decision, opinion/position date: 17/01/2013, EC decision date: 10/04/2013, Last updated: 02/05/2013contains two active substances: beclomethasone dipropionate, a corticosteroid … Master and associated names (beclomethasone dipropionate / formoterol … Master and associated names (beclomethasone dipropionate / formoterol … -
List item
Press release: PRAC reviews known risk of pneumonia with inhaled corticosteroids for chronic obstructive pulmonary disease
PRAC, Last updated: 18/03/2016that widens the airways). Beclomethasone, budesonide, flunisolide … that widens the airways). Beclomethasone, budesonide, 30 Churchill … -
List item
Referral: Inhaled corticosteroids containing medicinal products indicated in the treatment of chronic obstructive pulmonary disease
beclometasone, budesonide, flunisolide, fluticasone propionate, fluticasone furoate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 28/04/2016, EC decision date: 29/06/2016, Last updated: 15/07/2016include the active substances beclomethasone, budesonide, flunisolide … that widens the airways). Beclomethasone, budesonide, flunisolide … include the active substances beclomethasone, budesonide, flunisolide … -
List item
National expert: Kaisa Mari Hämäläinen, Finnish Medicines Agency
- Declaration of interests - 79.81 KB | PDF
- Curriculum Vitae - 22.36 KB | PDF
of the systemic effects of beclomethasone dipropionate inhaled via … -
List item
Human medicine European public assessment report (EPAR): Avamys
fluticasone furoate, Rhinitis, Allergic, Seasonal; Rhinitis, Allergic, Perennial
Date of authorisation: 11/01/2008, Revision: 22, Authorised, Last updated: 29/03/2022 -
List item
Human medicine European public assessment report (EPAR): Ritonavir Mylan (updated)
ritonavir, HIV Infections
Date of authorisation: 09/11/2017,
, Revision: 12, Authorised, Last updated: 06/05/2022
-
List item
Human medicine European public assessment report (EPAR): Telzir
fosamprenavir calcium, HIV Infections
Date of authorisation: 12/07/2004, Revision: 47, Authorised, Last updated: 11/04/2022 -
List item
Human medicine European public assessment report (EPAR): Revinty Ellipta
fluticasone furoate, vilanterol trifenatate, Asthma
Date of authorisation: 02/05/2014, Revision: 19, Authorised, Last updated: 10/11/2021 -
List item
Human medicine European public assessment report (EPAR): Relvar Ellipta
fluticasone furoate, vilanterol, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 13/11/2013, Revision: 21, Authorised, Last updated: 18/03/2022pulmonary disease (COPD) INNs: beclomethasone, budesonide, flunisolide … -
List item
Human medicine European public assessment report (EPAR): Skyrizi
Risankizumab, Psoriasis; Arthritis, Psoriatic
Date of authorisation: 26/04/2019,
, Revision: 11, Authorised, Last updated: 14/03/2022
-
List item
Human medicine European public assessment report (EPAR): Xolair
omalizumab, Asthma; Urticaria
Date of authorisation: 25/10/2005, Revision: 42, Authorised, Last updated: 16/12/2021 -
List item
Human medicine European public assessment report (EPAR): Atazanavir Mylan
atazanavir (as sulfate), HIV Infections
Date of authorisation: 22/08/2016,, Revision: 11, Authorised, Last updated: 03/02/2022
-
List item
Human medicine European public assessment report (EPAR): Lopinavir/Ritonavir Mylan
lopinavir, ritonavir, HIV Infections
Date of authorisation: 14/01/2016,, Revision: 13, Authorised, Last updated: 28/01/2022
-
List item
Human medicine European public assessment report (EPAR): BiResp Spiromax
budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 28/04/2014, Revision: 11, Authorised, Last updated: 09/06/2021 -
List item
Human medicine European public assessment report (EPAR): Atazanavir Krka
atazanavir (as sulfate), HIV Infections
Date of authorisation: 25/03/2019,, Revision: 1, Authorised, Last updated: 09/12/2021
-
List item
Human medicine European public assessment report (EPAR): DuoResp Spiromax
budesonide, formoterol fumarate dihydrate, Pulmonary Disease, Chronic Obstructive; Asthma
Date of authorisation: 28/04/2014, Revision: 11, Authorised, Last updated: 09/06/2021 -
List item
Human medicine European public assessment report (EPAR): Symtuza
darunavir, cobicistat, emtricitabine, tenofovir alafenamide, HIV Infections
Date of authorisation: 21/09/2017,, Revision: 12, Authorised, Last updated: 28/03/2022
-
List item
Human medicine European public assessment report (EPAR): Aptivus
tipranavir, HIV Infections
Date of authorisation: 25/10/2005, Revision: 41, Authorised, Last updated: 28/03/2022 -
List item
Human medicine European public assessment report (EPAR): BroPair Spiromax
salmeterol xinafoate, fluticasone propionate, Asthma
Date of authorisation: 26/03/2021, Revision: 1, Authorised, Last updated: 27/08/2021 -
List item
Human medicine European public assessment report (EPAR): Paxlovid (updated)
(1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxopyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido) butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide [PF-07321332], ritonavir, COVID-19 virus infection
Date of authorisation: 28/01/2022,
, Revision: 1, Authorised, Last updated: 29/04/2022
-
List item
Human medicine European public assessment report (EPAR): Seffalair Spiromax
fluticasone propionate, salmeterol xinafoate, Asthma
Date of authorisation: 26/03/2021, Authorised, Last updated: 23/08/2021 -
List item
Human medicine European public assessment report (EPAR): Reyataz
atazanavir (as sulfate), HIV Infections
Date of authorisation: 01/03/2004, Revision: 52, Authorised, Last updated: 18/02/2022